|
FBLN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.029200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87400999999143E-05 |
| Normal-vs-Stage2 |
1.827890E-04 |
| Normal-vs-Stage3 |
2.380100E-03 |
| Normal-vs-Stage4 |
8.477300E-03 |
| Stage1-vs-Stage2 |
4.687200E-01 |
| Stage1-vs-Stage3 |
2.821600E-01 |
| Stage1-vs-Stage4 |
6.939400E-01 |
| Stage2-vs-Stage3 |
9.685700E-02 |
| Stage2-vs-Stage4 |
2.600800E-01 |
| Stage3-vs-Stage4 |
9.469800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.610300E-04 |
| Normal-vs-AfricanAmerican |
7.8020000000012E-05 |
| Normal-vs-Asian |
4.457600E-01 |
| Caucasian-vs-AfricanAmerican |
6.771900E-02 |
| Caucasian-vs-Asian |
1.976750E-01 |
| AfricanAmerican-vs-Asian |
2.950600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.60970000000172E-05 |
| Normal-vs-Female |
4.799900E-02 |
| Male-vs-Female |
1.077630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.459000E-03 |
| Normal-vs-Extreme_Weight |
2.805100E-04 |
| Normal-vs-Obese |
3.446400E-04 |
| Normal-vs-Extreme_Obese |
2.26179999999188E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.741800E-01 |
| Normal_Weight-vs-Obese |
3.451200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.571960E-02 |
| Extreme_Weight-vs-Obese |
9.627800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.465800E-02 |
| Obese-vs-Extreme_Obese |
6.535900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.369650E-04 |
| Normal-vs-Age(41-60Yrs) |
3.800300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.020600E-04 |
| Normal-vs-Age(81-100Yrs) |
7.63670000000216E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.043400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.408400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.545200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.435600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.316620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.677250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.33209999999496E-05 |
| Normal-VS-Type2 PRCC |
5.244800E-04 |
| Normal-VS-KIRP CIMP |
5.181400E-03 |
| Normal-VS-Unclassified PRCC |
3.561600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.062300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.357560E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.134800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.249400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.874800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.254600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.611400E-04 |
| Normal-vs-N1 |
3.720300E-03 |
| Normal-vs-N2 |
4.223200E-01 |
| N0-vs-N1 |
3.638400E-01 |
| N0-vs-N2 |
2.701900E-03 |
| N1-vs-N2 |
8.965900E-02 |
|
|
